Obese patients with non-alcoholic fatty liver disease have an increase in soluble plasma CD163 and a concurrent decrease in hepatic expression of CD163
Dyk ned i forskningsemnerne om 'Obese patients with non-alcoholic fatty liver disease have an increase in soluble plasma CD163 and a concurrent decrease in hepatic expression of CD163'. Sammen danner de et unikt fingeraftryk.